Cytochrome P450 reductase Peptide

Cytochrome P450 reductase Peptide

• Description: For modified antibodies, we provide modified peptides(0.5mg) and non-modified peptides (0.5 mg).
• Reactivity: Antibody available as DF2613
• Source: Synthetic
• Applications: Blocking/Control
• Concentration: 10 mg/mL
• Function: Blocking peptides are peptides that bind specifically to the target antibody and block antibody binding. These peptide usually contains the epitope recognized by the antibody. Antibodies bound to the blocking peptide no longer bind to the epitope on the target protein. This mechanism is useful when non-specific binding is an issue, for example, in Western blotting (immunoblot) and immunohistochemistry (IHC). By comparing the staining from the blocked antibody versus the antibody alone, one can see which staining is specific; Specific binding will be absent from the western blot or immunostaining performed with the neutralized antibody.
• Precautions: This product is for research use only. Not for use in diagnostic or therapeutic procedures.
• Related Products: DF2613